Skip to main content
TipRanks
Go Ultimate75% OFF

Lyell Immunopharma (LYEL) Stock Forecast & Price Target

163 Followers
See the Price Targets and Ratings of:

LYEL Analyst Ratings

Moderate Buy
5Ratings
4Buy0Hold1Sell
Based on 5 analysts giving stock ratings to Lyell Immunopharma in the past 3 months

LYEL Stock 12 Month Forecast

$34.80▲(137.54% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Lyell Immunopharma in the last 3 months. The average price target is $34.80 with a high forecast of $44.00 and a low forecast of $12.00. The average price target represents a 137.54% change from the last price of $14.65.
Highest Price Target$44.00Average Price Target$34.80Lowest Price Target$12.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for LYEL
Price TargetArticle
Bank of America Securities$12sell-18.09%DownsideReiterated11/16/26
H.C. Wainwright$45→$39buy166.21%UpsideReiterated11/13/26
Stifel Nicolaus$36→$35buy138.91%UpsideReiterated11/05/26
B. Riley Securities$44buy200.34%UpsideReiterated09/24/26
Needham$44buy200.34%UpsideReiterated09/11/26
Robert W. Baird$49buy234.47%UpsideInitiated05/01/26
Citizens JMP$34buy132.08%UpsideInitiated03/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lyell Immunopharma

3 Months
Jason Zemansky
Jason ZemanskyBank of America Securities
Success Rate6/11 ratings generated profit
55%
Average Return
-1.55%

Copying Jason Zemansky's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of -1.55% per trade.

1 Year
Jason Zemansky
Jason ZemanskyBank of America Securities
Success Rate3/11 ratings generated profit
27%
Average Return
-27.11%

Copying Jason Zemansky's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -27.11% per trade.

2 Years
Jason Zemansky
Jason ZemanskyBank of America Securities
Success Rate3/11 ratings generated profit
27%
Average Return
-13.39%

Copying Jason Zemansky's trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of -13.39% per trade.

LYEL Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for LYEL
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy99998
Buy00000
Hold00000
Sell22112
Strong Sell00000
total1111101010

In the current month, LYEL has received 8 Buy Ratings, 0 Hold Ratings, and 2 Sell Ratings. LYEL average Analyst price target in the past 3 months is 34.80.

LYEL Financial Forecast

$-8$-6.25$-4.5$-2.75$-1Q1 2026Q3 2026Q4 2026
High$-1.57
Consensus$-1.86
Low$-2.54

LYEL Earnings Forecast

Next quarter’s earnings estimate for LYEL is -$1.86 with a range of -$2.54 to -$1.57. The previous quarter’s EPS was -$1.86. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$9,249.5$18,500$27,750.5$37,001Q1 2026Q3 2026Q4 2026
High$37K
Consensus$7K
Low$0.00

LYEL Sales Forecast

Next quarter’s sales forecast for LYEL is $7,000 with a range of $0 to $37.00K. The previous quarter’s sales results were $3,000. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

LYEL Stock Forecast FAQ

What is LYEL’s average 12-month price target, according to analysts?
Based on analyst ratings, Lyell Immunopharma’s 12-month average price target is $34.80.
What is LYEL’s upside potential, based on the analysts’ average price target?
Lyell Immunopharma has 137.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LYEL a Buy, Sell or Hold?
Lyell Immunopharma has a consensus rating of Moderate Buy which is based on 4 buy ratings, 0 hold ratings and 1 sell ratings.
What is Lyell Immunopharma’s price target?
The average price target for Lyell Immunopharma is $34.80. This is based on 5 12-month price targets, issued in the past 3 months. The highest analyst price target is $44.00, the lowest forecast is $12.00. The average price target represents a 137.54% increase from the current price of $14.65.
What do analysts say about Lyell Immunopharma?
Lyell Immunopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of LYEL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.